Trulieve Cannabis: The Only Pot Stock to Buy Right Now
Its no surprise to anyone that Cannabis has gotten absolutely obliterated over the past little while; many 'pot' stocks have dropped 200-300%, some 500%, and even a few over 500% over the past 6 months.
One of the small handful of stocks that has remained relatively in-tact technically is Trulieve. Despite several concerns in the sector, Trulieve appears to be doing it correctly.
Consistent record revenue, ebitda and growth are obvious signs of success. However, one of the key things with Trulieve that many seem to be struggling with is that they have the distribution to sell their product(s) and their CEO Kim Rivers is executing a well-formulated business plan.
Relative to peers, this stock is roughly 20-25% undervalued, and once the dust settles in the sector, I can see Trulieve picking up quite quickly to the $23-26 range: of course, never in a linear and straight-line.
For those that like the risk and speculation of the Cannabis sector, Trulieve is definitely my top pick.
- zSplit
One of the small handful of stocks that has remained relatively in-tact technically is Trulieve. Despite several concerns in the sector, Trulieve appears to be doing it correctly.
Consistent record revenue, ebitda and growth are obvious signs of success. However, one of the key things with Trulieve that many seem to be struggling with is that they have the distribution to sell their product(s) and their CEO Kim Rivers is executing a well-formulated business plan.
Relative to peers, this stock is roughly 20-25% undervalued, and once the dust settles in the sector, I can see Trulieve picking up quite quickly to the $23-26 range: of course, never in a linear and straight-line.
For those that like the risk and speculation of the Cannabis sector, Trulieve is definitely my top pick.
- zSplit